Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
about
Nonimmunologic targets of immunosuppressive agents in podocytesChitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses.A eukaryotic expression plasmid carrying chicken interleukin-18 enhances the response to newcastle disease virus vaccine.Contaminated cocaine and antineutrophil cytoplasmic antibody-associated diseaseImproving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvantsImmunomodulatory effect of various anti-parasitics: a review.Effect of liniment levamisole on cellular immune functions of patients with chronic hepatitis BNecrotizing and crescentic glomerulonephritis with membranous nephropathy in a patient exposed to levamisole-adulterated cocaineInfluence of levamisole and other angiogenesis inhibitors on angiogenesis and endothelial cell morphology in vitroThe effect of levamisole on mortality rate among patients with severe burn injuriesLevamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients.The podocyte as a target for therapies--new and old.Anthelmintic resistance in equine helminth parasites - a growing issue for horse owners and veterinarians in New Zealand?Adverse effects of levamisole in cocaine users: a review and risk assessment.Nephrotic syndrome in infants and children: pathophysiology and management.Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections.Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience.Treatment of chronic idiopathic urticaria with levamisole: a multicentre, randomized, double-blind, controlled trial.Levamisole: might it be used in treatment and prevention of atopic diseases?Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome.Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant.Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.
P2860
Q26781358-FFF68092-939D-4354-A505-5B19892D3DD3Q33846672-7CD66B85-0CA1-479C-A8D2-4A38657D522CQ34785006-C04355A8-5E8A-404E-BEB4-2E04C34B0CA7Q35664589-7A8EAF3B-5C3C-42F1-B4B8-33685F1C4406Q36279736-AE598062-31E2-430C-9F86-929188AB3F49Q36332836-79D5E4F1-0A47-4DC2-A723-E2C7D6003A97Q36496797-7E89C967-C590-45D5-95A1-0E898BEA48E4Q36689175-40405557-8E6A-4986-9CBE-F10073331E83Q37226482-FEF67A25-09DF-4B91-A863-5C53EBDB8A62Q37413748-D5C0B6DF-9584-49CB-B21F-6E867253F702Q37743569-D88F71F3-7685-440D-964B-FB8E72860BCBQ37951800-D2741927-4215-4B65-B24A-9F1578D429C3Q38327161-9E90F483-CAD1-4AA4-9AC7-64A2A26AF63EQ39185450-6DC01920-0F8C-4EF8-BE7E-9FC57405911AQ40039238-B367024B-E6FD-4F15-9C18-E7A93976D092Q40697828-0EE1A8F8-D5EE-47E9-99F0-EC914D731112Q42372585-01500393-A655-4367-9403-EC0B735F593AQ43275286-6B6F91F7-7508-406D-AD39-40BB01899E60Q45053706-5B564D0E-EBFC-4188-8833-0853E1EF3FDDQ47349419-305547C8-CAD3-4F77-9319-AA25F49D704EQ51097707-5B304A85-FC19-4281-A2C4-E660EAD42019Q53096179-6C1A5402-B166-4C87-9978-4B7C033ADA76Q53634292-93FB7C4E-2BAE-4FC3-B2AD-F54952345A07
P2860
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@ast
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@en
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@nl
type
label
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@ast
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@en
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@nl
prefLabel
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@ast
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@en
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@nl
P2093
P2860
P3181
P1433
P1476
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
@en
P2093
K M Gillespie
P W Mathieson
P2860
P304
P3181
P356
10.1046/J.1365-2567.2000.00042.X
P407
P577
2000-06-01T00:00:00Z